Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Li-Na He"'
Publikováno v:
Middle East Fertility Society Journal, Vol 29, Iss 1, Pp 1-10 (2024)
Abstract Accurate prediction of oocyte maturation is a critical determinant of success in in vitro fertilization-embryo transfer (IVF-ET) procedures. This review provides a comprehensive analysis of the various predictive approaches employed to asses
Externí odkaz:
https://doaj.org/article/3b4073647e0f49639ba15c7c43a5f432
Publikováno v:
BMC Bioinformatics, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background Uncovering functional genetic variants from an allele-specific perspective is of paramount importance in advancing our understanding of gene regulation and genetic diseases. Recently, various allele-specific events, such as allele
Externí odkaz:
https://doaj.org/article/d105233902ed4ddbaea29c914bce1154
Autor:
Li-Na He, Tao Chen, Sha Fu, Yongluo Jiang, Xuanye Zhang, Chen Chen, Wei Du, Linfeng Luo, Anlin Li, Yixing Wang, Hui Yu, Yixin Zhou, Yuhong Wang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Wenfeng Fang, Li Zhang, Shaodong Hong
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: For Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST1.1), measuring up to two target lesions per organ is an arbitrary criterion. Objectives: We sought to compare response assessment using RECIST1.1 and modified RECIST1.1
Externí odkaz:
https://doaj.org/article/b7a1963657ab463bae02eb2f78a4c360
Autor:
Li-Na He, Haifeng Li, Wei Du, Sha Fu, Linfeng luo, Tao Chen, Xuanye Zhang, Chen Chen, Yongluo Jiang, Yixing Wang, Yuhong Wang, Hui Yu, Yixin Zhou, Zuan Lin, Yuanyuan Zhao, Yan Huang, Hongyun Zhao, Wenfeng Fang, Yunpeng Yang, Li Zhang, Shaodong Hong
Publikováno v:
iScience, Vol 26, Iss 7, Pp 107058- (2023)
Summary: The immune and stromal contexture within the tumor microenvironment (TME) interact with cancer cells and jointly determine disease process and therapeutic response. We aimed at developing a risk scoring model based on TME-related genes of sq
Externí odkaz:
https://doaj.org/article/9435e0cd9f3d4bc2850761808524bced
Autor:
Yongluo Jiang, Yixing Wang, Sha Fu, Tao Chen, Yixin Zhou, Xuanye Zhang, Chen Chen, Li‐na He, Wei Du, Haifeng Li, Zuan Lin, Yuanyuan Zhao, Yunpeng Yang, Hongyun Zhao, Wenfeng Fang, Yan Huang, Shaodong Hong, Li Zhang
Publikováno v:
Thoracic Cancer, Vol 13, Iss 11, Pp 1558-1569 (2022)
Abstract Background Brain metastasis (BM) comprises the most common reason for crizotinib failure in patients with anaplastic lymphoma kinase (ALK)‐rearranged non–small cell lung cancer (NSCLC). We hypothesize that its occurrence could be predict
Externí odkaz:
https://doaj.org/article/1813850a98a94b6db579f9e23f06634c
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundThe leucine rich repeat containing 3B (LRRC3B) gene is a tumor suppressor gene involved in the anti-tumor immune microenvironment. Expression of LRRC3B and DNA methylation at the LRRC3B promoter region may serve as a useful marker to predic
Externí odkaz:
https://doaj.org/article/dc205bae119c4072a879f0f3f1b465d8
Autor:
Xuanye Zhang, Yixin Zhou, Hualin Chen, Chen Chen, Zuan Lin, Li-na He, Wei Du, Tao Chen, Shaodong Hong, Sha Fu
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundPulmonary lymphoepithelioma-like carcinoma (PLELC) is a distinctive subtype of non-small cell lung carcinoma that was not well presented in clinical studies. The management of advanced PLELC remains an important, unmet need due to the pauci
Externí odkaz:
https://doaj.org/article/ab2ad6a4ddf14278a29e41ada3a8349c
Autor:
Wen-Fei Wei, Chen-Fei Zhou, Xiang-Guang Wu, Li-Na He, Lan-Fang Wu, Xiao-Jing Chen, Rui-Ming Yan, Mei Zhong, Yan-Hong Yu, Li Liang, Wei Wang
Publikováno v:
Cell Death and Disease, Vol 13, Iss 12, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/6c001bfa48d2406197d7f54cf2c71e62
Autor:
Chen Chen, Yixin Zhou, Xuanye Zhang, Yuhong Wang, Li-na He, Zuan Lin, Tao Chen, Yongluo Jiang, Shaodong Hong, Li Zhang
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundMore and more immune-oncology trials have been conducted for treating various cancers, yet it is unclear what the reporting quality of immune-oncology trials is,and characteristics associated with higher reporting quality.ObjectiveThis stud
Externí odkaz:
https://doaj.org/article/33ebd35de7d24cdca3976daa01e1707a
Autor:
Li-na He, Xuanye Zhang, Haifeng Li, Tao Chen, Chen Chen, Yixin Zhou, Zuan Lin, Wei Du, Wenfeng Fang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Shaodong Hong, Li Zhang
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Tumor growth rate (TGR; percent size change per month [%/m]) is postulated as an early radio-graphic predictor of response to anti-cancer treatment to overcome limitations of RECIST. We aimed to evaluate the predictive value of pre-treatment TGR (TGR
Externí odkaz:
https://doaj.org/article/30715b95c2c24c239ea3a35129fc4dd3